INNOVATION PHARMACEUTICALS INC. Debt Instrument, Convertible, Conversion Price
INNOVATION PHARMACEUTICALS INC. had Debt Instrument, Convertible, Conversion Price of $0.10 per share as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2019-05-10
- 2019-03-31: Debt Instrument, Convertible, Conversion Price $0.10.
- 2018-12-31: Debt Instrument, Convertible, Conversion Price $0.09.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2019-03-31 | $0.10 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.09 10-Q · filed 2019-02-08 |